Upper GI 2017

MDCT - Restaging after neoadjuvant chemotherapy

• Predicted T stage correctly in 34 % (12/35) • Overstaged 49 % (17/35) • Understaged 17 % (6/35)*

Accurate N stage was noted in 69 % (24/35) •

• Assessment of oesophageal tumour response should focus on combined morphologic and metabolic imaging

*Konieczny, A., P. Meyer, et al. (2013). Eur Radiol 23(9): 2492-2502.